Bipartisan congressional lawmakers are striving to eliminate a contentious provision in a spending bill that would prevent the Justice Department from rescheduling marijuana.
Mace And Tlaib Lead The Charge
According to Marijuana Moment, Rep. Nancy Mace (R-SC) has introduced an amendment to strike the rescheduling restriction from the 2025 Commerce, Justice, Science and Related Agencies (CJS) spending bill.
“We want to make sure rescheduling happens,” Mace said in a video recorded at the Republican National Committee (RNC) convention. Rep. Rashida Tlaib (D-MI) has also proposed an amendment to remove the same section, which the House Appropriations Committee had adopted earlier this month.
Senate And House Efforts
Republican senators attempted to block the administration from rescheduling cannabis through a standalone bill introduced last September, but it has not advanced.
This activity aligns with the upcoming deadline for the cannabis rescheduling process on the DOJ’s proposal to reclassify marijuana from Schedule I to Schedule III under the Controlled Substances Act (CSA).
Controversy Over Hemp Products
Rep. Morgan McGarvey (D-KY) has introduced amendments to the Agriculture, Rural Development, Food and Drug Administration, and Related Agencies (Ag/FDA) spending bill to remove a provision that would ban most consumable hemp products.
His proposal would also affirm states’ rights to regulate hemp independently. The Ag/FDA bill report urges the FDA to intensify enforcement against unregulated cannabis products making unauthorized therapeutic claims.
D.C. And Psilocybin Legislation
Rep. Eleanor Holmes Norton (D-DC) has filed an amendment to the Financial Services and General Government (FSGG) spending bill to end the federal ban on Washington, D.C. using local tax dollars to implement adult-use marijuana sales. This restriction, sponsored by Rep. Andy Harris (R-MD), has been in place since 2014.
Rep. Robert Garcia (D-CA) has introduced amendments to various spending bills to prevent federal agencies from testing job applicants for marijuana and to protect state and local laws on medical psilocybin from Justice Department interference.
Veterans Affairs And Marijuana Recommendations
The House Rules Committee recently approved amendments to the Military Construction, Veterans Affairs, and Related Agencies (MilConVA) bill, allowing VA doctors to recommend medical marijuana to veterans and supporting psychedelics research.
The full House has passed these proposals as part of the MilConVA appropriations. Similarly, the Senate Appropriations Committee approved a spending bill amendment permitting VA doctors to discuss and recommend medical marijuana to patients in states where it is legal.
Read Next:
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Cannabis is evolving – don’t get left behind!
Curious about what’s next for the industry and how to leverage California’s unique market?
Join top executives, policymakers, and investors at the Benzinga Cannabis Market Spotlight in Anaheim, CA, at the House of Blues on November 12. Dive deep into the latest strategies, investment trends, and brand insights that are shaping the future of cannabis!
Get your tickets now to secure your spot and avoid last-minute price hikes.